Follow The Filings

CLVT Clarivate PLC

Information Technology, filed as CLARIVATE PLC (ORD SHS), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 exit

In 2026 Q2 Mason Hawkins sold out of Clarivate.

Who owns CLVT

Sorted by value, long equity only, as of 2026 Q2.

History
Mason Hawkins, Southeastern Asset Management exited 2026 Q2 Last 2026 Q1 0.02% Exit −0.02% 121,927 $308K History

0 current, 1 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by CLVT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CLVT insider trades
  • $9.4M bought by 2 insiders
  • $4.8M sold by 1 insider outside a trading plan
  • $1.2M sold by 1 insider under 10b5-1 plans
  1. Kenneth L. Cornick Director
    Buy
    $1.7M 900,000 shares at $1.86 +82% to stake
    Traded Aug 6–7 Filed Aug 10
    ↗
  2. Andrew Miles Snyder Director
    Sale
    $4.8M 2,489,618 shares at $1.94 27% of stake
    Traded Aug 3 Filed Aug 5
    ↗
  3. Bar Veinstein President, A&G
    Planned sale
    $1.2M 309,902 shares at $3.74 27% of stake
    Traded Dec 1, 2025 Filed Dec 2, 2025
    ↗
  4. Kenneth L. Cornick Director
    Buy
    $345K 100,000 shares at $3.45 +10% to stake
    Traded Nov 10, 2025 Filed Nov 13, 2025
    ↗
  5. Kenneth L. Cornick Director
    Buy
    $2.5M 725,000 shares at $3.42 +264% to stake
    Traded Oct 31, 2025–Nov 3, 2025 Filed Nov 3, 2025
    ↗
  6. Andrew Miles Snyder Director
    Buy
    $4.9M 1,460,000 shares at $3.33 +185% to stake
    Traded Oct 31, 2025 Filed Nov 3, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 37 share withholdings for taxes, 35 stock grants, 1 gift, and 1 other transaction.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
8-K/A 2.01,9.01 Filing Doc
8-K 2.01,5.02,8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 1.01,5.02,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.07,8.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $2.63B $2.56B $2.46B
Gross profit * $1.72B $1.69B $1.62B
Gross margin * 65.5% 66.0% 66.0%
Net income -$911.2M -$636.7M -$201.1M
Net margin * -34.7% -24.9% -8.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.46B $1.24B $1.31B
Total non-current assets * $11.24B $10.25B $9.76B
Total assets $12.71B $11.49B $11.07B
Total current liabilities $1.6B $1.43B $1.57B
Total non-current liabilities * $5.11B $4.92B $4.66B
Total equity $5.99B $5.14B $4.84B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $744.2M $646.6M $628.5M
Cash from investing -$237.4M -$236.7M -$263.2M
Cash from financing -$496.5M -$470.1M -$343.1M
Net change in cash $13.9M -$75.5M $34M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.